Expertise in
6
conditions
Expertise in
6
conditions
Henry Joyce Cancer Clinic
2220 Pierce Ave, 
Nashville, TN 

Overview

Debra Friedman is a Hematologist and an Oncologist practicing medicine in Nashville, Tennessee.

Dr. Friedman is highly rated in 6 conditions, according to our data. Her clinical expertise encompasses Hodgkin Lymphoma, Retinoblastoma, Febrile Neutropenia, and Agranulocytosis.

She is actively involved in clinical research, co-authoring 141 peer reviewed articles and participating in 24 clinical trials. Dr. Friedman is currently accepting new patients.

Specialties

Hematology
Oncology

Licenses

Pediatric Hematology-Oncology in WA

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Alliant Health
  • HMO
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Oscar
  • EPO
  • HMO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
View 5 Less Insurance Carriers -

Locations

Henry Joyce Cancer Clinic
2220 Pierce Ave, Nashville, TN 37232

Additional Areas of Focus

Dr. Friedman has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Immune Thrombocytopenic Purpura (ITP)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


24 Clinical Trials

Risk-Stratified Therapy for Acute Myeloid Leukemia in Down Syndrome
A Phase 2 Study of Inotuzumab Ozogamicin (NSC# 772518) in Children and Young Adults With Relapsed or Refractory CD22+ B-Acute Lymphoblastic Leukemia (B-ALL)
A Phase III Randomized Trial Investigating Bortezomib (NSC# 681239) on a Modified Augmented BFM (ABFM) Backbone in Newly Diagnosed T-Lymphoblastic Leukemia (T-ALL) and T-Lymphoblastic Lymphoma (T-LLy)
Risk-Stratified Randomized Phase III Testing of Blinatumomab (NSC#765986) in First Relapse of Childhood B-Lymphoblastic Leukemia (B-ALL)
A Randomized Phase 3 Study of Brentuximab Vedotin (SGN-35) for Newly Diagnosed High-Risk Classical Hodgkin Lymphoma (cHL) in Children and Young Adults
View 9 Less Clinical Trials

141 Total Publications

NCCN Guidelines® Insights: Survivorship, Version 3.2026.
Similar Doctors
Expertise in
24
conditions
Hematology | Oncology
Expertise in
24
conditions
Hematology | Oncology
Referral may be required

Scri Oncology Partners

335 24th Ave N, Ste 200, 
Nashville, TN 
 (0.9 miles away)
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Erika Hamilton, MD, is an independent medical oncologist and hematologist at Ascension Saint Thomas in Nashville, Tennessee. Dr. Hamilton diagnoses and treats adults with cancer and focuses on managing care during and after chemotherapy, radiation therapy and surgery. Every appointment with Dr. Hamilton starts with a conversation. She takes the time to answer all your questions — big and small. Dr. Hamilton is highly rated in 24 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, HER2 Negative Breast Cancer, Ovarian Cancer, and HER-2 Positive Breast Cancer. Dr. Hamilton is board certified in The American Board Of Internal Medicine - Medical Oncology. Dr. Hamilton is currently accepting new patients.

Expertise in
5
conditions
Hematology | Oncology
Expertise in
5
conditions
Hematology | Oncology
Referral may be required

Vanderbilt Children's Hematology-Oncology

2200 Childrens Way # 6, 
Nashville, TN 
 (2.1 miles away)
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Michael Debaun is a Hematologist and an Oncologist practicing medicine in Nashville, Tennessee. Dr. Debaun is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Sickle Cell Disease, Congenital Hemolytic Anemia, Hemoglobinopathy, Hemolytic Anemia, and Bone Marrow Transplant. Dr. Debaun is currently accepting new patients.

Expertise in
21
conditions
Hematology | Oncology
Expertise in
21
conditions
Hematology | Oncology
Referral may be required

Scri Oncology Partners

335 24th Ave N, Ste 200, 
Nashville, TN 
 (0.9 miles away)
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Denise Yardley is a Hematologist and an Oncologist practicing medicine in Nashville, Tennessee. Dr. Yardley is highly rated in 21 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Triple-Negative Breast Cancer, HER-2 Positive Breast Cancer, and Paget Disease of the Breast. Dr. Yardley is currently accepting new patients.

Frequently Asked Questions about Dr. Debra L. Friedman

How do I make an appointment with Dr. Debra L. Friedman?

You can book an appointment with Dr. Debra L. Friedman by calling their office at 615-936-1762. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Debra L. Friedman a top-rated expert for Hodgkin Lymphoma?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Debra L. Friedman is classified as an Distinguished expert for Hodgkin Lymphoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Debra L. Friedman specialize in?

While Dr. Debra L. Friedman is a Hematology, they have specific expertise in Hodgkin Lymphoma, Retinoblastoma, and Febrile Neutropenia. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.

Does Dr. Debra L. Friedman participate in research or clinical trials?

Yes. Dr. Debra L. Friedman has published 141 articles and abstracts on conditions like Hodgkin Lymphoma. You can view a list of Dr. Debra L. Friedman's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Debra L. Friedman accept my insurance?

Dr. Debra L. Friedman accepts most major insurance plans, including Aetna and Alliant Health. We recommend calling the office directly at 615-936-1762 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Friedman's expertise for a condition
ConditionClose
    View All 19 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile